Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum
Authors:
- 11 December 2013
- journal article
- Published by Springer Nature in Parasitology Research
- Vol. 113 (3) , 925-931
Abstract
Praziquantel is currently the only drug of choice for the treatment of human Schistosoma japonicum infections, and praziquantel-based chemotherapy has been proved to be generally effective to control the morbidity and reduce the prevalence and intensity of S. japonicum infections. However, the potential emergence of praziquantel resistance in S. japonicum seriously threatens the elimination of this neglected tropical disease in China. The purpose of this study was designed, in mouse animals, to evaluate the in vivo efficacy of artemether and artesunate against praziquantel non-susceptible S. japonicum. Mice infected with a praziquantel non-susceptible isolate and a praziquantel-susceptible isolate of S. japonicum were treated with artemether and artesunate at a single oral dose of 300 mg/kg given once on each of days 7–8 and 35–36 post-infection to assess the efficacy against juvenile and adult worms. Administration with artemether and artesunate at a single oral dose of 300 mg/kg on each of days 7–8 post-infection resulted in total worm burden reductions of 72.8 and 73.5 % in mice infected with praziquantel-susceptible S. japonicum, and 77.9 and 74.1 % in mice infected with the non-susceptible isolate (both P values >0.05), while the same treatments given on days 35–36 post-infection reduced total worm burdens by 71.4 and 69.6 % in mice infected with the susceptible isolate, and 75.3 and 69.6 % in mice infected with the non-susceptible parasite (both P values >0.05). It is concluded that there is no evidence for reduced susceptibility of artemether and artesunate in praziquantel non-susceptible S. japonicum.Keywords
This publication has 68 references indexed in Scilit:
- New approaches for understanding mechanisms of drug resistance in schistosomesParasitology, 2013
- Factors impacting on progress towards elimination of transmission of schistosomiasis japonica in ChinaParasites & Vectors, 2012
- Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysisParasites & Vectors, 2011
- A diagnostic challenge for schistosomiasis japonica in China: consequences on praziquantel-based morbidity controlParasites & Vectors, 2011
- The challenge of effective surveillance in moving from low transmission to elimination of schistosomiasis in ChinaInternational Journal for Parasitology, 2011
- Research and Development of Antischistosomal Drugs in the People's Republic of ChinaAdvances in Parasitology, 2010
- Reduced Susceptibility to Praziquantel among Naturally Occurring Kenyan Isolates of Schistosoma mansoniPLOS Neglected Tropical Diseases, 2009
- Towards an understanding of the mechanism of action of praziquantelMolecular and Biochemical Parasitology, 2009
- The future of artemisinins: natural, synthetic or recombinant?Journal of Biology, 2008
- Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at riskThe Lancet Infectious Diseases, 2006